Europe is set to become the world’s largest legal cannabis market over the next five years (2023) as European countries begin to legalize medical cannabis for domestic use and export to other EU countries.
Germany has permitted the use of medical cannabis since 2017. The medical cannabis programs and the state’s obligation to cover medical prescriptions are still being developed but will be among the most robust and will set the standards for Europe.
As a first mover, AMP will quickly establish market leadership in Germany due to its proven German and European management team, unique import model and ability to meet supply requirements through multiple suppliers from different countries that meet the EU-GMP standard.
Providing pharmaceutical grade (EU-GMP) cannabis to German patients through imports from Canada and other countries.